Showing results (1-10 of 421) with videos related to

Sort By:
Pageof 43
The Urologic Clinics of North America|May 9, 2003
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trialsRobin Leach, Brad Pollock, Joseph Basler, et al.
Urologic Oncology|April 15, 2004
Relationship of body mass index and prostate specific antigen in a population-based studyIan M Thompson, Robin Leach, Dean Troyer, et al.
Urologic Oncology|April 10, 2003
Challenges and opportunities to the design and implementation of chemoprevention trials for prostate cancerIan M Thompson, Joseph A Basler, Robin Leach, et al.
Urology|May 10, 2011
Trends and co-trends of prostate-specific antigen and body mass index in a screened populationDonna P Ankerst, Brad H Pollock, Yuanyuan Liang, et al.
Clinical Prostate Cancer|March 26, 2004
Prostate cancer prevention: what do we know now and when will we know more?Ian M Thompson, Joseph Basler, Deborah Hensley, et al.
The Journal of Urology|July 24, 2007
Chemoprevention of prostate cancer: agents and study designsIan M Thompson
The Journal of Urology|November 7, 2006
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratificationIan M Thompson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Overdiagnosis and overtreatment of prostate cancerIan M Thompson
Drugs of Today (Barcelona, Spain : 1998)|May 24, 2003
Pharmacologic agents in complementary medicine in prostatic diseaseIan M. Thompson
Prostate Cancer and Prostatic Diseases|November 3, 2018
Higher baseline dietary fat and fatty acid intake is associated with increased risk of incident prostate cancer in the SABOR studyMichael A Liss, Osamah Al-Bayati, Jonathan Gelfond, et al.
Pageof 43